I 115th CONGRESS 1st Session H. R. 2025 IN THE HOUSE OF REPRESENTATIVES April 6, 2017 Mr. Griffith (for himself and Mr. Costello of Pennsylvania ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend section 505(c)(3)(E) of the Federal Food, Drug, and Cosmetic Act to prevent certain applications from being considered ineligible for approval under section 505(c) of such Act on the basis that the proposed labeling includes information describing abuse-deterrent properties that otherwise would be blocked by exclusivity under clause (iii) or (iv) of section 503(c)(3)(E) of such Act, and for other purposes.